Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome
Abstract Background Acute intermittent porphyria (AIP) is a rare but treatable disease. COVID-19 has various possible complications including posterior reversible encephalopathy syndrome (PRES). COVID-19 was reported to trigger an acute attack in patients with acute hepatic porphyria (AHP). The path...
Saved in:
| Main Authors: | Hideo Handa, Hiroki Masuda, Satoki Hanayama, Amika Kajiyama, Sawako Suzuki, Atsuhiko Sugiyama, Koutaro Yokote, Satoshi Kuwabara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Neurology |
| Online Access: | https://doi.org/10.1186/s12883-025-04159-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Intermittent Porphyria, Posterior Reversible Encephalopathy Syndrome and Hypertensive Emergency, A Review of The Literature
by: Mohamed A. Ahmed, et al.
Published: (2020-05-01) -
First presentation of acute intermittent porphyria with steroid-responsive encephalopathy associated with autoimmune thyroiditis
by: M. W. K. De Zoysa, et al.
Published: (2025-03-01) -
Porphyria Presenting as Diffuse Encephalopathy
by: J Gordon Millichap
Published: (2005-05-01) -
Unmasking Osmotic Demyelination Syndrome/Extrapontine Myelinolysis in Acute Intermittent Porphyria: Preventable Complications–Challenges in Diagnosis and Management
by: Vykuntaraju K Gowda, et al.
Published: (2025-05-01) -
Acute intermittent porphyria after gastroplasty
by: Alzira Alves Siqueira Carvalho, et al.
Published: (2011-12-01)